Sign in to continue:

Wednesday, January 28th, 2026

OCBC Stock Analysis: Bullish Trend Continues with 27% Upside Potential









Comprehensive Stock Analysis: OCBC, Li Auto, Parkway Life REIT, and More

Comprehensive Stock Analysis: OCBC, Li Auto, Parkway Life REIT, and More

Broker: CGS International Securities

Date of Report: February 10, 2025

Oversea-Chinese Banking Corporation Ltd (OCBC): Bullish Momentum Continues

Oversea-Chinese Banking Corporation Ltd (OCBC) has shown remarkable resilience and growth as its bullish uptrend continues. The stock, currently priced at S\$17.33, is recommended as a technical buy based on sustained positive momentum. The analysis suggests that OCBC is poised for further gains, supported by multiple technical indicators.

Key Technical Insights:

  • Entry Prices: S\$17.33, S\$16.90, S\$16.30
  • Support Levels: S\$16.96, S\$15.70
  • Stop Loss: S\$15.65
  • Resistance Levels: S\$17.61, S\$18.92
  • Target Prices: S\$18.90, S\$19.88, S\$20.90, S\$22.11

Technical Indicators Driving the Recommendation:

  • The formation of a symmetrical triangle/pennant pattern signals a strong potential for the continuation of the uptrend.
  • The psychological level of S\$17.00 has acted as a solid support.
  • Prices are trending above all Ichimoku indicators, reinforcing the bullish phase.
  • MACD and signal lines remain elevated above the zero line, with a positive histogram.
  • The stochastic oscillator shows no significant bearish pressure, despite a slight decline.
  • The 23-period Rate of Change (ROC) has risen above the zero line.
  • Volume has surged above the 20-period average, confirming healthy bullish momentum.

OCBC has already exceeded its third target price of S\$17.20 (as per the November 8, 2024, recommendation), and this new analysis indicates further upward potential. Investors are encouraged to maintain their technical buy positions.

Li Auto Inc (2015): A Technical Buy Opportunity

Li Auto Inc, a major player in the electric vehicle industry, has been identified as a technical buy. The stock exhibits strong potential for upward momentum, with key entry prices and target levels outlined in the report.

Recommendation Details:

  • Entry Prices: HK\$103.20, HK\$94.10, HK\$84.80
  • Stop Loss: HK\$82.14
  • Target Prices: HK\$130.80, HK\$154.54, HK\$176.30, HK\$200.00

The recommendation is based on technical indicators that suggest a strong buy opportunity. Investors are advised to consider the outlined entry points and stop-loss levels to manage risk effectively.

Parkway Life REIT: A Healthy Outlook

Parkway Life REIT continues to demonstrate a robust financial position, making it an attractive investment opportunity. With its defensive income structure in Singapore and contributions from European properties, the REIT is expected to deliver strong growth in FY2025.

Key Financial Highlights:

  • 2H24/FY24 Distribution Per Unit (DPU): 7.38/14.92 Singapore cents, in line with forecasts.
  • DPU Achievements: 49.3% of 2H24 forecast, 99.7% of FY24 forecast.
  • Forecast for FY2025: Robust DPU growth driven by stable income streams and full-year contributions from European acquisitions.

Recommendation:

  • Rating: Add
  • Target Price: S\$4.91 (based on a discounted dividend model)

Parkway Life REIT’s strong fundamentals and growth outlook make it a solid addition to any portfolio focused on stable and defensive investments.

Additional Market Insights

Beyond individual stock analysis, the report also delves into broader market trends and strategies:

China Strategy: A Year of Revaluation

China’s market is undergoing a revaluation phase with significant implications for investors. The report encourages a careful evaluation of opportunities within this evolving landscape.

Siloam International Hospitals: Resolving Private Insurance Issues

Siloam International Hospitals in Indonesia is expected to overcome challenges related to private insurance, paving the way for improved financial performance.

Bangchak Corporation: Rising Operational Headwinds

Bangchak Corporation in Thailand is facing operational challenges that may impact its short-term performance. Investors are advised to monitor developments closely.

Disclaimer: The content above has been prepared by CGS International Securities and is intended for informational purposes only. It does not constitute financial advice. Investors are encouraged to conduct their own research and consult financial professionals before making investment decisions.


“Q&M Dental Group Expands AI Solutions, Boosts Profitability in Southeast Asia”

KGI Securities (Singapore) Pte. Ltd. March 28, 2025 Q&M Dental Group Expands AI Footprint and Streamlines Operations for Improved Profitability Expansion of AI Solutions Business EM2AI, a 49%-owned associate of Q&M Dental, has secured...

Lendlease Global Commercial REIT: Positive Retail Reversions and Improving Office Occupancy

Comprehensive Analysis of Lendlease Global Commercial REIT and Its Peers Comprehensive Analysis of Lendlease Global Commercial REIT and Its Peers Broker: CGS International Date: February 4, 2025 Lendlease Global Commercial REIT (LREIT) Lendlease Global...

OUE REIT Singapore 2026 Outlook: Dividend Growth, Sydney Acquisition, ESG Momentum & Forecasts

Broker: CGS International Date of Report: January 28, 2026 Excerpt from CGS International report. Report Summary OUE REIT delivered a strong FY25, with a Distribution Per Unit (DPU) of 2.23 Singapore cents, exceeding expectations...